Marginal zone lymphoma: Associated autoimmunity and auto-immune disorders

Area of Science:

• Immunology
• Oncology
• Epidemiology

Background:

• Autoimmune disorders (AID) are linked to an increased risk of lymphoma development.
• This association is particularly strong for certain AID, such as Sjögren's syndrome and Hashimoto's thyroiditis, and specific non-Hodgkin lymphoma (NHL) subtypes, including marginal zone lymphoma (MZL) and MALT lymphoma.

Purpose of the Study:

• To provide an overview of the epidemiological aspects of the association between NHL and AID.
• To focus on marginal zone lymphomas, which are frequently associated with AID.
• To review potential biological mechanisms and risk factors involved in AI-related lymphomas.

Main Methods:

• Review of large epidemiological studies.
• Analysis of the association between specific autoimmune disorders and non-Hodgkin lymphoma subtypes.
• Examination of pathobiological mechanisms and risk factors.

Main Results:

• A consistent increased risk for lymphoma in patients with autoimmune disorders has been observed.
• Factors such as advanced age, prolonged disease course, and disease severity may increase lymphoma risk in AID patients.
• AI-related lymphomas may represent a distinct spectrum with unique pathobiology, clinical features, and treatment considerations.

Conclusions:

• The link between autoimmune disorders and lymphoma, especially marginal zone lymphomas, is well-established.
• Understanding the pathobiology and risk factors is crucial for managing AI-related lymphomas.
• AI-related lymphomas warrant specific clinical attention due to their distinct characteristics.